Myelodysplastic syndromes trials in Austria

4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  Where

  Innsbruck, Linz, Rankweil, Salzburg, Vienna

  Age

  18 years to 75 years

  People

  650 worldwide

  Run by

  University of Ulm

  See details and how to joinNCT04628026 · EU 2023-507518-28-00
• No phaseNot yet taking people in Austria
  CHIP in Health and Disease

  Where

  Innsbruck

  Age

  18 years and over

  People

  120

  Run by

  VASCage GmbH

  See details and how to joinNCT07780552
• Phase 2Taking people
  (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  Where

  Vienna

  Age

  18 years and over

  People

  140 worldwide

  Run by

  Cogent Biosciences, Inc.

  See details and how to joinNCT04996875 · EU 2024-511407-42-00
• Phase 2Enrolling by invitation
  A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

  Where

  Vienna

  Age

  18 years and over

  People

  332 worldwide

  Run by

  Taiho Oncology, Inc.

  See details and how to joinNCT04093570 · EU 2024-516293-29-01